Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)

9.66
Delayed Data
As of 10:32am ET
 -0.088 / -0.90%
Today’s Change
6.10
Today|||52-Week Range
20.63
-17.06%
Year-to-Date

Today’s Trading

Previous close9.75
Today’s open9.93
Day’s range9.58 - 9.93
Volume7,223
Average volume (3 months)70,372
Market cap$81.6M
Dividend yield--
Data as of 10:32am ET, 07/24/2017

Growth & Valuation

Earnings growth (last year)+71.93%
Earnings growth (this year)+34.54%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio7.8
Price/Sales--
Price/Book2.00

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...+0.27+4.01%
NVETNexvet Biopharma plc-0.01-0.15%
IPCIIntellipharmaceutics...-0.20-7.43%
CXRXConcordia Internatio...+0.06+3.95%
Data as of 10:49am ET, 07/24/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$1.27
Annual revenue (last year)$0.00
Annual profit (last year)-$47.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David A. Cory
Chief Financial &
Principal Accounting Officer
James H. Welch
Corporate headquarters
Palo Alto, California

Forecasts